Understanding how tick immune cells respond to Rickettsia parkeri infection

The Role of Hemocytes in tick Rickettsia parkeri infection

['FUNDING_R21'] · UNIVERSITY OF SOUTHERN MISSISSIPPI · NIH-10993667

This study is looking at how tick immune cells respond to a specific germ that can cause diseases in humans, with the goal of finding new ways to stop ticks from spreading these illnesses, especially as tick-borne diseases are becoming more common.

Quick facts

Phase['FUNDING_R21']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF SOUTHERN MISSISSIPPI (nih funded)
Locations1 site (HATTIESBURG, UNITED STATES)
Trial IDNIH-10993667 on ClinicalTrials.gov

What this research studies

This research investigates the immune response of tick hemocytes, which are similar to human immune cells, to the Rickettsia parkeri pathogen. By analyzing how these immune cells interact with the infection, the study aims to uncover new strategies to prevent the transmission of tick-borne diseases. The researchers will utilize advanced techniques like RNA sequencing to identify immune factors that could be targeted for developing new treatments or preventive measures against these infections. This work is particularly important as tick-borne diseases are on the rise due to climate change.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals living in areas where tick-borne diseases are prevalent, particularly those at risk of Rickettsia parkeri infection.

Not a fit: Patients who do not live in tick-endemic regions or who are not at risk for tick-borne diseases may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new methods for preventing tick-borne diseases in humans.

How similar studies have performed: While the specific focus on tick hemocytes and Rickettsia parkeri is relatively novel, similar research on tick immunity has shown promise in understanding vector-borne diseases.

Where this research is happening

HATTIESBURG, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.